Wolverine Trading’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Wolverine Trading’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8,700	Closed	-$937K	–	5213
2023 Q1	$937K	Sell	8,700 -16,300	-65%	-$1.88M	﹤0.01%	1950
2022 Q4	$2.75M	Buy	+25,000	New	+$1.62M	﹤0.01%	1210

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Wolverine Trading's RXDX Position: Q2 2023 in Review

Wolverine Trading sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 3,075 shares — an estimated $331K sold.

Wolverine Trading first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $884K in Q4 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Wolverine Trading reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Wolverine Trading sold 3,075 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $331K.
Wolverine Trading first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Wolverine Trading's Prometheus Biosciences, Inc. Common Stock position peaked at $884K in Q4 2022.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.